迈瑞医疗
(300760)
| 流通市值：3692.97亿 | | | 总市值：3692.98亿 |
| 流通股本：12.12亿 | | | 总股本：12.12亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 9,372,811,209 | 34,931,900,884 | 27,303,797,964 | 18,475,773,496 |
| 营业收入 | 9,372,811,209 | 34,931,900,884 | 27,303,797,964 | 18,475,773,496 |
| 二、营业总成本 | 6,073,471,557 | 21,991,204,875 | 16,548,221,666 | 11,451,529,589 |
| 营业成本 | 3,190,131,192 | 11,820,708,329 | 9,251,094,921 | 6,356,227,937 |
| 税金及附加 | 100,808,593 | 366,077,263 | 288,037,305 | 185,206,248 |
| 销售费用 | 1,485,484,939 | 5,702,924,130 | 3,989,365,767 | 2,834,582,023 |
| 管理费用 | 473,351,126 | 1,523,748,134 | 1,115,793,687 | 795,641,115 |
| 研发费用 | 947,431,880 | 3,432,658,732 | 2,508,923,742 | 1,851,429,618 |
| 财务费用 | -123,736,173 | -854,911,713 | -604,993,756 | -571,557,352 |
| 其中:利息费用 | 4,465,076 | 12,996,889 | 8,818,027 | 5,545,091 |
| 其中:利息收入 | 189,758,820 | 821,643,445 | 526,335,326 | 292,212,391 |
| 加:公允价值变动收益 | 126,027,777 | 79,401,838 | 60,837,032 | 33,176,206 |
| 加:投资收益 | -3,098,705 | -9,840,894 | -4,950,533 | -1,797,920 |
| 资产处置收益 | -316,183 | 2,464,577 | 4,319,764 | -113,618 |
| 资产减值损失(新) | -43,448,954 | -529,505,736 | -120,053,114 | -76,853,744 |
| 信用减值损失(新) | -66,413,250 | -244,194,525 | -60,415,250 | -56,868,456 |
| 其他收益 | 260,188,187 | 830,836,564 | 565,377,484 | 408,181,672 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 3,572,278,524 | 13,069,857,833 | 11,200,691,681 | 7,329,968,047 |
| 加:营业外收入 | 7,474,965 | 56,347,903 | 36,129,071 | 18,176,959 |
| 减:营业外支出 | 22,038,680 | 115,275,709 | 49,837,637 | 38,353,604 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 3,557,714,809 | 13,010,930,027 | 11,186,983,115 | 7,309,791,402 |
| 减:所得税费用 | 395,924,083 | 1,432,516,623 | 1,351,457,445 | 866,578,823 |
| 六、净利润 | 3,161,790,726 | 11,578,413,404 | 9,835,525,670 | 6,443,212,579 |
| 持续经营净利润 | 3,161,790,726 | 11,578,413,404 | 9,835,525,670 | 6,443,212,579 |
| 归属于母公司股东的净利润 | 3,159,898,674 | 11,582,226,085 | 9,834,303,940 | 6,441,990,849 |
| 少数股东损益 | 1,892,052 | -3,812,681 | 1,221,730 | 1,221,730 |
| (一)基本每股收益 | 2.61 | 9.56 | 8.12 | 5.32 |
| (二)稀释每股收益 | 2.61 | 9.56 | 8.12 | 5.32 |
| 八、其他综合收益 | -116,262,405 | 272,830,698 | 199,121,815 | 322,167,973 |
| 归属于母公司股东的其他综合收益 | -109,942,296 | 271,645,344 | 199,121,815 | 322,167,973 |
| 九、综合收益总额 | 3,045,528,321 | 11,851,244,102 | 10,034,647,485 | 6,765,380,552 |
| 归属于母公司股东的综合收益总额 | 3,049,956,378 | 11,853,871,429 | 10,033,425,755 | 6,764,158,822 |
| 归属于少数股东的综合收益总额 | -4,428,057 | -2,627,327 | 1,221,730 | 1,221,730 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-28 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |